Promoting and Encouraging Family Planning Activities Fuels Contraceptives Market

The best way to reduce the risk of sexually transmitted diseases among men and women, and unintended pregnancies among women and teenagers is to use effective contraceptives and birth control. Depending upon the correct and consistent use of contraceptive pills, shots, rings, and patches, and barrier, fertility awareness-based, and hormonal options, the chances of preventing STDs and unplanned pregnancies are quite high.

Even though the contraceptives market is a large one, it has been growing at a rather modest rate. According to Transparency Market Research, the global contraceptives market is anticipated to register a 3.10% CAGR from 2014 to 2020, expanding from a value of US$15.7 bn in 2013 to US$19.6 bn in 2020.

Let’s take a look at some of the major developments in the contraceptives market that made news this month.


New Law in Two US States Allows Sale of Contraceptives without Doctor Visit 

Women in Oregon and California will soon be able to purchase birth control without getting a prescription from a doctor. By presenting necessary information to a pharmacist in the form of a questionnaire regarding their medical history, contraceptives such as patches, pills, and rings will be sold to women in these two US states. The new law is designed to make contraceptives more convenient and affordable to women and address the increasing rates of unintended pregnancies. According an article in the New York Times, an estimated 3.3 million annual pregnancies in the US are unintended. Those advocating the new law are planning to convince other states to adopt similar proposals.

Women in World’s Poorest Countries Report Unprecedented Use of Modern Contraceptives 

A report released by Family Planning 2020 in the second week of November reveals that more number of girls and women in the world’s poorest countries have been voluntarily using modern contraceptives to delay or avoid a pregnancy. Since 2012, there have been an additional 24.4 million women and girls using contraceptives. This has resulted in the averting of 111,000 maternal deaths, 26.8 million unsafe abortions, and 80 million unintended pregnancies. These numbers indicate the progress these countries have made in enabling women to access family planning methods. 

Oral Contraceptives May Reduce Symptoms of Rheumatoid Arthritis

A new study shows that patients of rheumatoid arthritis who take oral contraceptives are likely to witness a reduction in their symptoms. The pill may help quell severe swelling, pain, stiffness, and inflammation associated with rheumatoid arthritis. A professor at Germany’s University Hospital Regensburg and one of the authors of the study, Dr. Rainer Straub said that oral contraceptives could work because they locally affect the central nervous system. Arthritis Research UK stresses on the strong link between hormones and arthritis, which forms the basis of this study.    


The global contraceptives market is characterized by the presence of strong players such as Reckitt Benckiser plc, CooperSurgical, Inc., Bayers AG, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Actavis, Inc., Church & Dwight, Co., Inc., The Female Health Company, Merck & Co., Inc., and Mayer Laboratories, Inc.

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports